Dinesh Thakur is a naturalised US citizen of Indian origin who in 2002 took up a post with the dynamic pharma company Ranbaxy. The transnational is famous for making a range of popular generic – or out of patent – drugs that are sold around the world.
Relocated to the firm’s facility outside Delhi, Thakur was tasked to scrutinize the data that Ranbaxy submitted for approvals to the US and other foreign markets. He found that test results were being falsified for HIV anti-retroviral and other drugs; he also came across sloppy manufacturing processes.
